Health X Platform Limited Rebrands, Reports ₹1,231 Crore Revenue

Health X Platform Limited, previously known as Sastasundar Ventures Ltd, announced its consolidated revenue reached ₹1,231.33 crore for the full year ending December 31, 2025. The company's healthcare operations were the primary driver, generating ₹1,209.72 crore.

Name Change and Financial Update

The formal name change from Sastasundar Ventures Limited to Health X Platform Limited has been certified by the company's Statutory Auditors, adhering to SEBI regulations. This announcement also detailed the revenue breakdown for the full year 2025: total consolidated revenue stood at ₹1,231.33 crore, with healthcare activities contributing ₹1,209.72 crore and financial services accounting for the remaining ₹21.61 crore.

Strategic Rationale Behind the Rebrand

This rebranding to Health X Platform Limited signals a strategic shift, positioning the company more broadly within healthcare, digital platforms, and related services. The significant revenue generated by the healthcare segment underscores its dominant role in the company's operations.

Historical Context of the Transformation

The transformation to Health X Platform Limited, approved in early 2026, aimed to broaden the company's scope into healthcare, pharmaceuticals, wellness, and digital platform services. This strategic shift followed approvals from the board and regulatory bodies, including the Registrar of Companies and the Ministry of Corporate Affairs. Historically, the company has operated in both financial services and a healthcare network, utilizing an online-to-offline business model.

Implications for Shareholders

Shareholders will now recognize the company under its new identity, Health X Platform Limited. The rebranding points to a renewed emphasis on its digital health ecosystem strategy. The revenue breakdown clearly highlights the dominant contribution of the healthcare segment, reinforcing its importance for the company's operations and future growth.

Performance Disparities and Past Challenges

Although the company has rebranded to focus on healthcare, its financial services segment contributes a minimal portion of overall revenue, indicating a disparity in segment performance. Historically, the company has navigated challenges with operating losses and thin margins, though recent consolidated results have shown a turnaround.

Competitive Environment

Health X Platform Limited operates within a competitive digital health and e-pharmacy landscape in India. Key rivals include Tata 1mg, PharmEasy, Netmeds, and Practo, all of which offer a range of services from online medicine sales to diagnostics and consultations, utilizing technology to improve healthcare access.

What to Watch Moving Forward

The company is expected to issue a Revised CA certificate to shareholders. Investors will likely monitor the strategic outcomes of the rebranding, the ongoing performance of the dominant healthcare segment compared to the smaller financial services arm, and future expansion plans and operational efficiencies under the Health X Platform Limited identity.